Arcturus Therapeutics Holdings (ARCT) Short-term Investments (2023 - 2025)

Arcturus Therapeutics Holdings (ARCT) has 3 years of Short-term Investments data on file, last reported at $55.0 million in Q3 2025.

• Quarterly Short-term Investments changed 0.0% year-over-year to $55.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $55.0 million (changed 0.0% YoY) and the FY2024 annual result came in at $55.0 million, changed 0.0% from the prior year.
• Short-term Investments held at $55.0 million in Q3 2025, from $55.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $55.0 million in Q4 2023 to a low of $38.5 million in Q1 2025.
• A 3-year average of $52.9 million and a median of $55.0 million in 2023 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments changed 0.0% — and 2025, when it tumbled 30.0%.
• Tracing ARCT's Short-term Investments over 3 years: stood at $55.0 million in 2023, then changed by 0.0% to $55.0 million in 2024, then changed by 0.0% to $55.0 million in 2025.
• The last three Short-term Investments figures came in at $55.0 million (Q3 2025), $55.0 million (Q2 2025), and $38.5 million (Q1 2025), per Business Quant data.